Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6479627 | 0.91 | KMT2A (0.43) | KMT2ALMNAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL6492924 | 0.88 | LMNA (0.39) | KMT2ALMNAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL6482175 | 0.85 | MEN1 (0.39) | KMT2AALDH1A1SMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL3612812 | 0.81 | MEN1 (0.38) | KMT2AALDH1A1SMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL587253 | 0.81 | KMT2A (0.34) | KMT2ALMNAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL587876 | 0.80 | MEN1 (0.38) | KMT2AALDH1A1MEN1CYP1A2CYP2C19 | |
| SCHEMBL6483187 | 0.78 | MEN1 (0.35) | KMT2ALMNAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL6495177 | 0.76 | CYP1A2 (0.36) | KMT2AALDH1A1SMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL587146 | 0.76 | MAPK1 (0.43) | KMT2ALMNAALDH1A1MEN1HSD17B10 | |
| SCHEMBL6480978 | 0.74 | LMNA (0.38) | KMT2ALMNAALDH1A1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | YANAGI AKIHIKO (JP) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | DDT, TTI1, CYP1A1 | KMT2A 1800/4885LMNA 4295/4885ALDH1A1 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.